AU612475B2 - Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them - Google Patents

Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them Download PDF

Info

Publication number
AU612475B2
AU612475B2 AU32243/89A AU3224389A AU612475B2 AU 612475 B2 AU612475 B2 AU 612475B2 AU 32243/89 A AU32243/89 A AU 32243/89A AU 3224389 A AU3224389 A AU 3224389A AU 612475 B2 AU612475 B2 AU 612475B2
Authority
AU
Australia
Prior art keywords
formula
diphosphonate
tetraethyl
compounds
hydroxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU32243/89A
Other languages
English (en)
Other versions
AU3224389A (en
Inventor
Craig Bentzen
Pierre Maechler
Lan Nguyen
Eric Niesor
Hieu Phan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ilex Oncology Research SARL
Original Assignee
Symphar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphar SA filed Critical Symphar SA
Publication of AU3224389A publication Critical patent/AU3224389A/en
Application granted granted Critical
Publication of AU612475B2 publication Critical patent/AU612475B2/en
Assigned to ILEX ONCOLOGY RESEARCH S.A. reassignment ILEX ONCOLOGY RESEARCH S.A. Request to Amend Deed and Register Assignors: SYMPHAR S.A.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/386—Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3865—Polyphosphonic acids containing sulfur substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids
    • C07F9/404—Esters of poly(thio)phosphonic acids containing hydroxy substituents in the hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids
    • C07F9/4043—Esters of poly(thio)phosphonic acids containing sulfur substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/44—Amides thereof
    • C07F9/4403—Amides thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4423—Amides of poly (thio)phosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU32243/89A 1988-03-31 1989-03-30 Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them Ceased AU612475B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1239/88A CH675422A5 (enExample) 1988-03-31 1988-03-31
CH1239/88 1988-03-31

Publications (2)

Publication Number Publication Date
AU3224389A AU3224389A (en) 1989-10-05
AU612475B2 true AU612475B2 (en) 1991-07-11

Family

ID=4205733

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32243/89A Ceased AU612475B2 (en) 1988-03-31 1989-03-30 Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (2) US5043330A (enExample)
EP (1) EP0339237B1 (enExample)
JP (1) JPH0822865B2 (enExample)
KR (1) KR0147830B1 (enExample)
CN (2) CN1086820A (enExample)
AR (1) AR247569A1 (enExample)
AT (1) ATE84040T1 (enExample)
AU (1) AU612475B2 (enExample)
CA (1) CA1338495C (enExample)
CH (1) CH675422A5 (enExample)
DE (2) DE339237T1 (enExample)
DK (1) DK173936B1 (enExample)
ES (1) ES2011210T3 (enExample)
FI (1) FI92933C (enExample)
GR (2) GR900300002T1 (enExample)
HU (1) HU203556B (enExample)
IE (1) IE62692B1 (enExample)
IL (1) IL89649A (enExample)
MY (1) MY103850A (enExample)
NO (1) NO891317L (enExample)
NZ (1) NZ228516A (enExample)
PH (1) PH27603A (enExample)
PT (1) PT90175B (enExample)
ZA (1) ZA892126B (enExample)
ZW (1) ZW3789A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0377894A (ja) * 1989-08-18 1991-04-03 Toray Ind Inc メチレンジホスホン酸化合物
US5157027A (en) * 1991-05-13 1992-10-20 E. R. Squibb & Sons, Inc. Bisphosphonate squalene synthetase inhibitors and method
JPH05163150A (ja) * 1991-05-13 1993-06-29 E R Squibb & Sons Inc アテローム性動脈硬化症の抑制・治療剤
CA2067974A1 (en) * 1991-05-13 1992-11-14 Scott A. Biller Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor
ATE165603T1 (de) * 1991-09-05 1998-05-15 Toray Industries Methandiphosphonsäurederivat, herstellung davon und verwendung davon als arzneimittel
JPH06172372A (ja) * 1991-11-06 1994-06-21 Takeda Chem Ind Ltd スクアレン合成酵素阻害剤およびその用途
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
FR2683529B1 (fr) * 1991-11-12 1994-02-04 Bretagne Occidentale Universite Composes pharmaceutiques gem-diphosphonates analogues du cis-platine.
CH683996A5 (fr) * 1992-03-05 1994-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
EP0603401B1 (en) * 1992-07-10 2001-04-11 Toray Industries, Inc. Methanediphosphonate derivative, production thereof, and pharmaceutical use thereof
US5332728A (en) * 1992-11-23 1994-07-26 Bristol-Myers Squibb Company Method for treating a fungal infection
US5434288A (en) * 1992-12-01 1995-07-18 Monsanto Company PLA2 inhibitors
ZA941088B (en) * 1993-02-19 1995-09-27 Symphar Sa Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
CN1038033C (zh) * 1993-02-25 1998-04-15 东丽株式会社 甲基二膦酸化合物的制备方法
US5419845A (en) * 1994-03-15 1995-05-30 Basf Corporation Perfluorinated gemdiphosphonates as corrosion inhibitors for antifreeze coolants and other functional fluids
AU699641B2 (en) * 1994-08-24 1998-12-10 Toray Industries, Inc. Process for production of methanediphosphonic acid compound
CH690163A5 (fr) * 1995-07-28 2000-05-31 Symphar Sa Dérivés gem-diphosphonates substitués utiles en tant qu'agents anti-cancers.
GB9603637D0 (en) * 1996-02-21 1996-04-17 Smithkline Beecham Plc Process
AU2783397A (en) * 1996-05-15 1997-12-05 University Of Sheffield, The Isopentenyl pyrophosphate isomerase (ipi) and/or prenyl transferase inhibitors
US6670398B2 (en) * 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
EA200800375A1 (ru) * 1997-05-14 2008-06-30 Атеродженикс, Инк. Соединения и способы ингибирования экспрессии vcam-1
IL125336A0 (en) * 1998-07-14 1999-03-12 Yissum Res Dev Co Compositions for inhibition and treatment of restinosis
US7008645B2 (en) 1998-07-14 2006-03-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of inhibiting restenosis using bisphosphonates
US6984400B2 (en) 1998-07-14 2006-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating restenosis using bisphosphonate nanoparticles
AUPQ872800A0 (en) * 2000-07-12 2000-08-03 Heart Research Institute, The Compositions and methods for treating cardiovascular disorders
GB0019272D0 (en) * 2000-08-04 2000-09-27 Symphar Sa Pharmaceutical compounds
WO2002087556A2 (en) * 2001-04-11 2002-11-07 Atherogenics, Inc. Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
WO2003032909A2 (en) * 2001-10-18 2003-04-24 Ilex Products, Inc. Methods of treating skin with diphosphonate derivatives
EP1485106A2 (en) * 2002-02-19 2004-12-15 Ilex Products, Inc. Phosphonate-phosphate and diphosphonate apolipoprotein e modulators
US20060205692A1 (en) * 2002-05-11 2006-09-14 Montes Imber F 1,1-and 1,2-Bisphosphonates as apoliprotein e modulators
US7479507B2 (en) * 2003-01-14 2009-01-20 Adam Heller Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs
US10517883B2 (en) 2003-06-27 2019-12-31 Zuli Holdings Ltd. Method of treating acute myocardial infarction
EP2001486A4 (en) * 2006-03-17 2010-12-29 Univ Illinois BIPHOSPHONATE COMPOUNDS AND CORRESPONDING METHODS
JP2010522762A (ja) * 2007-03-26 2010-07-08 サルトリア・フアーマシユーテイカルズ・エル・エル・シー 糖尿病の治療のための方法及びプロブコール誘導体の組成物
US20080280985A1 (en) * 2007-03-27 2008-11-13 Scott Robert A D Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
EP3209671B8 (en) * 2014-10-21 2019-07-31 Council of Scientific and Industrial Research Alkylidene phosphonate esters as p-glycoprotein inducers
WO2018236221A2 (en) * 2017-06-03 2018-12-27 Can Holding B.V. Neurodegenerative peptide deposit dissolution

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU536326B2 (en) * 1979-02-13 1984-05-03 Symphar S.A. Diphosphonate derivatives
AU566880B2 (en) * 1982-07-29 1987-11-05 Sanofi-Aventis Sulphur containing methylene diphosphonates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA777769A (en) * 1963-03-18 1968-02-06 H. Roy Clarence Substituted methylene diphosphonic acid compounds and detergent compositions
DE1302557B (enExample) * 1963-04-09 1971-08-26
US4416877A (en) * 1979-02-13 1983-11-22 Symphar S.A. Anti-atherosclerotic pharmaceutical compositions containing diphosphonate compounds
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.
US6259935B1 (en) * 1997-06-24 2001-07-10 Matsushita Electrical Industrial Co., Ltd. Electro-mechanical-acoustic transducing device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU536326B2 (en) * 1979-02-13 1984-05-03 Symphar S.A. Diphosphonate derivatives
AU566880B2 (en) * 1982-07-29 1987-11-05 Sanofi-Aventis Sulphur containing methylene diphosphonates

Also Published As

Publication number Publication date
AU3224389A (en) 1989-10-05
CA1338495C (en) 1996-07-30
PH27603A (en) 1993-08-31
FI891538L (fi) 1989-10-01
HUT50482A (en) 1990-02-28
CN1024555C (zh) 1994-05-18
EP0339237A2 (en) 1989-11-02
NO891317D0 (no) 1989-03-29
US5128331A (en) 1992-07-07
KR890014569A (ko) 1989-10-24
EP0339237B1 (en) 1992-12-30
DK148189D0 (da) 1989-03-28
ES2011210A4 (es) 1990-01-01
DK148189A (da) 1989-10-17
ZA892126B (en) 1989-11-29
ATE84040T1 (de) 1993-01-15
FI891538A0 (fi) 1989-03-30
JPH0822865B2 (ja) 1996-03-06
CH675422A5 (enExample) 1990-09-28
DE339237T1 (de) 1990-02-08
DK173936B1 (da) 2002-02-25
US5043330A (en) 1991-08-27
JPH0222285A (ja) 1990-01-25
MY103850A (en) 1993-09-30
AR247569A1 (es) 1995-01-31
EP0339237A3 (en) 1991-01-09
FI92933C (fi) 1995-01-25
ZW3789A1 (en) 1989-08-23
KR0147830B1 (ko) 1998-08-17
DE68904104T2 (de) 1993-06-17
GR900300002T1 (en) 1991-06-07
PT90175B (pt) 1994-06-30
CN1036772A (zh) 1989-11-01
DE68904104D1 (de) 1993-02-11
FI92933B (fi) 1994-10-14
NZ228516A (en) 1990-12-21
CN1086820A (zh) 1994-05-18
NO891317L (no) 1989-10-02
HU203556B (en) 1991-08-28
GR3007442T3 (enExample) 1993-07-30
PT90175A (pt) 1989-11-10
ES2011210T3 (es) 1994-01-01
IL89649A0 (en) 1989-09-28
IL89649A (en) 1995-07-31
IE62692B1 (en) 1995-02-22
IE890802L (en) 1989-09-30

Similar Documents

Publication Publication Date Title
EP0339237B1 (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
FI89493B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva, fosforhaltiga inhibitorer av HMG-CoA-reduktas och vid foerfarandet anvaendbar ny mellanprodukt
US4904646A (en) Phosphorus-containing HMG-COA reductase inhibitors
US5017716A (en) Phosphorous-containing HMG-CoA reductase inhibitors, new intermediates and method
PT97214A (pt) Processo para a preparacao de acidos benzilfosfonicos inibidores da quinase da tirosina
EP0559079B1 (en) Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
CA1284320C (en) 2-substituted-1,3-propylidenediphosphonate derivatives, and the process for their preparation
DK149609B (da) Analogifremgangsmaade til fremstilling af hydroxyamino-alkan- eller -alkenphosphonsyrederivater eller estere eller salte deraf
US5374628A (en) Aryl and heteroaryl(phosphinylmethyl)phosphonate squalene synthetase inhibitors and method
CZ119893A3 (en) Novel derivatives of methylene-bisphosphonic acid
US4006204A (en) Phosphoric acid diesters
EP0409181A2 (en) Phosphorus-containing squalene synthetase inhibitors and method for their preparation
JP2929236B2 (ja) カルシウム代謝異常による疾病用治療剤
US5025003A (en) Isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5212164A (en) Phosphorus-containing squalene synthetase inhibitors
US4853476A (en) Phosphorus containing compounds as inhibitors of enkephalinases
US5273969A (en) Phosphorus-containing squalene synthetase inhibitors and method
US5107011A (en) Isoprenoid phosphinylformic acid squalene synthetase inhibitors and method
US5166386A (en) Process of making isoprenoid phosphinylformic acid squalene synthetase inhibitors
GB2235924A (en) Phosphorus-containing 3-hydroxy-butanoic acid intermediates
CN1306963A (zh) 一种缩合反应和用该缩合反应制备的磷脂类化合物及其衍生物

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: ILEX ONCOLOGY RESEARCH S.A.

Free format text: FORMER NAME WAS: SYMPHAR S.A.